CLINICAL_TRIALS
trial_result
· 2021-05-11
Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta [Phase 2]
Summary
Phase 2 clinical trial update on safety, pharmacokinetics, and pharmacodynamics of BPS804 in Osteogenesis Imperfecta completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Osteogenesis Imperfecta | Phase 2 | Status: COMPLETED